Update on serologic testing in COVID–19

Serologic tests are one of the available diagnostic tools in COVID–19. Growing literature highlights their role in the clinical management of the disease. Unfortunately, due to the limited availability of commercial tests and the lack of reliable trials establishing the sensitivity and specificity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajewski, Rafał, Gołębiowska, Justyna, Makuch, Sebastian, Mazur, Grzegorz, Agrawal, Siddarth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491380/
https://www.ncbi.nlm.nih.gov/pubmed/32946795
http://dx.doi.org/10.1016/j.cca.2020.09.015
Descripción
Sumario:Serologic tests are one of the available diagnostic tools in COVID–19. Growing literature highlights their role in the clinical management of the disease. Unfortunately, due to the limited availability of commercial tests and the lack of reliable trials establishing the sensitivity and specificity of the diagnostic method, the clinical application of the test needs to be precisely determined. In this paper, we discuss the utility of anti–SARS–CoV–2 serology testing in a clinical setting and propose diagnostic algorithms that include serological tests in patients with confirmed or suspected COVID–19.

Ejemplares similares